A program to help people with glaucoma stick to their medication
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
This study is all about helping people with glaucoma, especially those from different backgrounds, stick to their medication plans by using a friendly app and support system that makes managing their eye health easier and more effective.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10912481 on NIH RePORTER |
What this research studies
This research focuses on improving medication adherence among glaucoma patients, particularly those from diverse backgrounds, including African Americans and individuals with lower socio-economic status. The SEE Program provides personalized education and support through an eHealth application, motivational interviewing, and reminder systems to help patients manage their condition effectively. By addressing the unique self-management needs of these patients, the program aims to enhance their adherence to prescribed treatments and ultimately reduce vision loss associated with glaucoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are glaucoma patients, especially African Americans and those from lower socio-economic backgrounds, who struggle with medication adherence.
Not a fit: Patients who do not have glaucoma or those who are already adherent to their glaucoma medication may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for glaucoma patients by reducing the risk of vision loss through better medication adherence.
How similar studies have performed: Previous research has shown that tailored education and motivational interviewing can effectively improve medication adherence in similar patient populations.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Newman-Casey, Paula Anne — University of Michigan at Ann Arbor
- Study coordinator: Newman-Casey, Paula Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.